Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (9,296,960)	$ (4,983,768)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and depreciation	1,645,846	281,641
Common stock and stock option based compensation for employees and board of directors	2,784,667	2,102,271
Acquisition contingent consideration fair value adjustment	(677,113)
Impairment of intangible assets	479,182
Issuance of common stock to vendors as compensation	5,238	162,895
Amortization of right-to-use-assets	342,285
Loss on conversion of convertible notes		279,730
Forgiveness of Paycheck Protection Program loan		(623,828)
Changes in operating assets and liabilities:
Accounts receivable	(48,340)	(328,582)
Pre-offering costs		470,136
Deferred costs/contract assets	519,673	(5,082)
Prepaid expenses and other current assets	(120,436)	(423,010)
Other assets	149,962	(48,000)
Accounts payable	(525,832)	(80,164)
Accrued liabilities	3,987	(58,014)
Accrued bonuses	(153,660)	(440,357)
Deferred revenue/contract liabilities	(2,348,561)	14,418
Lease liabilities	(357,341)
Net cash used in operating activities	(7,597,403)	(3,679,714)
Cash flow from investing activities:
Purchases of equipment	(139,420)	(166,928)
Acquisitions, net of cash acquired	(2,522,756)	(3,815,894)
Asset acquisition		(300,000)
Purchase of investments	(8,197)	(242,160)
Net cash used in investing activities	(2,670,373)	(4,524,982)
Cash flows from financing activities:
Proceeds from initial public offering, net		11,821,364
Proceeds from securities purchase agreement, net		13,578,400
Proceeds from exercise of stock options	66,111	1,326,043
Issuance of note receivable		(250,000)
Net cash provided by financing activities	66,111	26,475,807
Net change in cash, cash equivalents and restricted cash	(10,201,665)	18,271,111
Cash, cash equivalents and restricted cash, beginning of period	18,249,666	1,771,929
Cash, cash equivalents and restricted cash, end of period	8,048,001	20,043,040
Non-cash Investing and Financing activities:
Common stock issued for acquisitions	2,845,430	3,347,303
Common stock issued for satisfaction of prior year acquisition lability	734,036
Common stock issued for purchase of intangible asset - technology	326,436
Issuance of common stock for satisfaction of contingent liability, net of note extinguishment	318,571
Extinguishment of note receivable for satisfaction of contingent liability	250,000
Contingent acquisition consideration liability recorded at closing	6,139,000	9,169,200
Issuance of common stock for satisfaction of contingent liability	1,359,001
Lease liabilities arising from right-of-use assets	1,221,513
Issuance of common stock for satisfaction of legacy acquisition liability		1,250,000
Conversion of convertible promissory notes into common stock		1,606,176
Issuance of warrants in connection with initial public offering		522,360
Issuance of warrants in connection with securities purchase agreement		$ 8,797,546